Publications Search Year - Year -2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980197919781977197619751974197319721971 Month - Month -JanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Sort by Publication Year Publication Year - OldestPublication Year - Newest C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve -Cell Function: Report of an ADA Workshop, 21-22 October 2001 Jan 1, 2004 Second-trimester cervical sonography: features other than cervical length to predict spontaneous preterm birth 2004 Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants Sep 2004 C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001 Jan 2004 The Society for Clinical Trials supports United States legislation mandating trials registration Oct 2004 Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort May 2003 The Fun, Food, and Fitness Project (FFFP): the Baylor GEMS pilot study 2003 What we have learned about antenatal prediction of neonatal morbidity and mortality 2003 Autoimmune response to advanced glycosylation end-products of human LDL 2003 What we have learned about preeclampsia 2003 Common design elements of the Girls health Enrichment Multi-site Studies (GEMS) 2003 Weight gain with intensive therapy but not conventional therapy of type 1 diabetes in DCCT is greater than a non-diabetic population (CARDIA): Follow-up from 1985–1993 2003 Pagination « First First page ‹‹ Previous page … 127 128 129 130 131 132 133 134 135 … ›› Next page Last » Last page
